OSU-ERb-12 treatment can significantly inhibit such ALDH−-to-ALDH+ cell conversion in both cell lines (Figure 3B–E), indicating that OSU-ERb-12 reduces the abundance of the CSC subpopulation by compromising cancer cell dedifferentiation. The gene discussed is LDHA; the disease is cancer.